Publication

Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors

ANNÉE

2021

AUTEURS

Meillan N, Orthuon A, Chauchat P, Atlani D, Bouche O, Chaulin B, David C, Deberne M, Debrigode C, Kao W, Keller A, Laharie H, Lamezec B, Lemanski C, Magné N, Mahé MA, Mere P, Moureau-Zabotto L, Peiffert D, Pointreau Y, Quéro L, Racadot S, Roca S, Sargos P, Servagi S, Tang E, Vendrely V, Doyen J, Huguet F

CONGRÈS/REVUE

Radiother Oncol

Etude

PRODIGE 2-UNICANCER-ACCORD12/0405

Localisation

Cancer du Rectum et du Canal

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.radonc.2021.06.006

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients

ANNÉE

2021

AUTEURS

Palle J, Hirsch L, Lapeyre-Prost A, Malka D, Bourhis M, Pernot S, Marcheteau E, Voron T, Castan F, Lacotte A, Benhamouda N, Tanchot C, François E, Ghiringhelli F, de la Fouchardière C, Zaanan A, Tartour E, Taieb J, Terme M

CONGRÈS/REVUE

Cancers (Basel)

Etude

PRODIGE 17-UNICANCER-ACCORD200904/0904 MEGA

Localisation

Cancer de l’Œsophage et de l’Estomac

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.3390/cancers13215562

Impact of Laparoscopy on Oncological Outcomes after Colectomy for Stage III Colon Cancer: A Post-Hoc Multivariate Analysis from PETACC8 European Randomized Clinical Trial

ANNÉE

2021

AUTEURS

Voron T, Karoui M, Lo Dico R, Malicot K L, Espin E, Cianchi F, Jürgen W, Buggenhout A, Bruzzi M, Denimal F, Cazelles A, Douard R, Lepage C, Taieb J

CONGRÈS/REVUE

Dig Liver Dis

Etude

PRODIGE 1-FFCD-PETACC8

Localisation

Cancer du Côlon non métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.dld.2021.05.012

Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial

ANNÉE

2020

AUTEURS

Aparicio T, Bennouna J, Le Malicot K, Boige V, Taieb J, Bouche O, Phelip JM, Francois E, Borel C, Faroux R, Dahan L, Bachet JB, Egreteau J, Kaminsky MC, Gornet JM, Cojocarasu O, Gasmi M, Guerin-Meyer V, Lepage C, Ghiringhelli F

CONGRÈS/REVUE

Br J Cancer

Etude

PRODIGE 9-FFCD-0802

Localisation

Cancer Colorectal Métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1038/s41416-020-0735-8

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma

ANNÉE

2020

AUTEURS

Niogret J, Limagne E, Thibaudin M, Blanc J, Bertaut A, Le Malicot K, Rinaldi Y, Caroli-Bosc FX, Audemar F, Nguyen S, Sarda C, Lombard-Bohas C, Locher C, Carreiro M, Legoux JL, Etienne P.-L, Baconnier M, Porneuf M, Aparicio T, Ghiringhelli F

CONGRÈS/REVUE

Cancers (Basel)

Etude

PRODIGE 9-FFCD-0802

Localisation

Cancer Colorectal Métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.3390/cancers12061429

Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

ANNÉE

2020

AUTEURS

Guilloteau A, Abrahamowicz M, Boussari O, Jooste V, Aparicio T, Quantin C, Le Malicot K, Binquet C

CONGRÈS/REVUE

BMC Med Res Methodol

Etude

PRODIGE 9-FFCD-0802

Localisation

Cancer Colorectal Métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1186/s12874-020-01202-9

Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study

ANNÉE

2020

AUTEURS

Manfredi S, Turpin A, Malka D, Barbier E, Laurent-Puig P, Zaanan A, Dahan L, Lièvre A, Phelip JM, Michel P, Hautefeuille V, Legoux JL, Lepage C, Tougeron D, Aparicio T

CONGRÈS/REVUE

Dig Liver Dis

Etude

PRODIGE 71-FFCD-1710 BEVAMAINT

Localisation

Cancer Colorectal Métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.dld.2020.06.034

Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial

ANNÉE

2020

AUTEURS

Taïeb J, Benhaim L, Laurent Puig P, Le Malicot K, Emile JF, Geillon F, Tougeron D, Manfredi S, Chauvenet M, Taly V, Lepage C, André T

CONGRÈS/REVUE

Dig Liver Dis

Etude

PRODIGE 70-FFCD-1802 CIRCULATE

Localisation

Cancer du Côlon non métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.dld.2020.04.010

PRODIGE 65 - UCGI 36 - GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma

ANNÉE

2020

AUTEURS

De la Fouchardière C, Hammel P,Launay S,Vienot A, Raimbourg J, Perrier H, Evesque L, Ghiringhelli F, Jary M, Aparicio T, Hociné F, Neuzillet Cindy, Botsen D, Phelip JM, Peytier A, Michel P, Cropet C, Lachaux N, Chabaud S, Dahan L

CONGRÈS/REVUE

ESMO

Etude

PRODIGE 65-UNICANCER-UCGI 36 GEMPAX

Localisation

Cancer du Pancréas

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.annonc.2020.08.2049

Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study

ANNÉE

2020

AUTEURS

Randrian V, Adenis A, Desrame J, Barbier E, Di Fiore F, Lievre A, Dahan L, Laurent-Puig P, Mineur L, Breysacher G, Roquin G, Louafi S, Lopez A, Louvet C, Borg C, Metges JP, Faroux R, Gaba L, Manfredi S, Tougeron D

CONGRÈS/REVUE

Dig Liver Dis

Etude

PRODIGE 62-FFCD-1701 OESIRI

Localisation

Cancer de l’Œsophage et de l’Estomac

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.dld.2019.11.014